Project Grant R21AI189794
- Federal Project Grant Award Summary The National Institute of Allergy and Infectious Diseases (NIAID) awarded the University of North Carolina at Chapel Hill $115,123 under the Allergy and Infectious Diseases Research program (CFDA 93.855) on August 20, 2025, with a completion date of July 31, 2027. This Project Grant supports research titled "Inside Out: Revealing Strategies for Intracellular S. Aureus Persister Eradication," which investigates the mechanisms underlying...
- Federal Project Grant Award Summary Yale University received a $453,629 Project Grant from the National Institute of Allergy and Infectious Diseases under the Allergy and Infectious Diseases Research program (CFDA 93.855) effective July 8, 2025, through June 30, 2027. The award supports the development and application of PHAGE-SEQ, a novel high-throughput technology that combines phage display of nanobodies (camelid-derived heavy chain-only immunoglobulins) with DNA sequencing to comprehensively...
- Federal Grant Award Summary Yale University received a $3.26 million Project Grant from the National Institute of Allergy and Infectious Diseases (NIAID) under the Allergy and Infectious Diseases Research program (CFDA 93.855), awarded August 1, 2025, with a completion date of July 31, 2029. This four-year research initiative focuses on elucidating the molecular mechanisms underlying Mycobacterium tuberculosis (MTB) cell envelope assembly to inform the development of synergistic tuberculosis...
- Federal Grant Award Summary Washington State University received a $153,000 Project Grant award from the National Institute of Allergy and Infectious Diseases (NIAID) under the Allergy and Infectious Diseases Research program (CFDA 93.855), effective August 1, 2025, through July 31, 2027. The grant supports the development of RNAi (RNA interference)-mediated gene silencing methods targeting Xenopsylla cheopis, the oriental rat flea, which serves as a primary vector for plague transmission caused...
- Federal Grant Award Summary Duke University's Office of Research Administration received a $127,527 Project Grant award from the National Institute of Allergy and Infectious Diseases (NIAID) under the Allergy and Infectious Diseases Research program (CFDA 93.855), effective November 1, 2025, with completion targeted for April 30, 2028. The award supports biomedical research investigating the role of the RGS12 locus in macrophage function, specifically examining how the RGS12B protein...
- Federal Grant Award Summary The National Institute of Allergy and Infectious Diseases (NIAID) awarded a Project Grant of $194,940 to the University of Pennsylvania under the Allergy and Infectious Diseases Research program (CFDA 93.855) on August 12, 2025, with completion targeted for July 31, 2030. This research initiative focuses on identifying and characterizing human genetic regulators of macrophage antimicrobial responses to Mycobacterium tuberculosis (MTB) infection. The project builds...
- Federal Project Grant Award Summary Princeton University received a $451,000 project grant from the National Institute of Allergy and Infectious Diseases (NIAID) under the Allergy and Infectious Diseases Research program (CFDA 93.855), awarded July 23, 2025, with completion scheduled for June 30, 2027. The grant funds research utilizing chemical synthetic lethality—a methodology whereby two individually benign molecules become lethal in combination—to identify novel antimicrobial targets and...
- Federal Grant Award Summary East Carolina University received a $224,078 Project Grant from the National Institute of Allergy and Infectious Diseases (NIAID) under the Allergy and Infectious Diseases Research program (CFDA 93.855) awarded August 13, 2025, with a completion date of July 31, 2027. This research project investigates the role of Annexin A1 (ANXA1) expression in Human T-cell Leukemia Virus Type 1 (HTLV-1)-mediated pathogenesis and the development of Adult T-cell Leukemia (ATL). The...
- Federal Grant Award Summary The National Institute of Allergy and Infectious Diseases (NIAID) awarded the University of Pennsylvania a Project Grant of $446,875 under the Allergy and Infectious Diseases Research program (CFDA 93.855) to conduct investigator-initiated biomedical research on filoviral pathogenesis. The award, obligated on September 16, 2025, with a completion date of August 31, 2027, funds research examining the nuclear localization and functional interactions of the Ebola virus...
- Federal Project Grant Award Summary The National Institute of Allergy and Infectious Diseases (NIAID) awarded the University of North Carolina at Charlotte a $778,934 Project Grant under the Allergy and Infectious Diseases Research program (CFDA 93.855) effective August 1, 2025, through July 31, 2030. This award supports a multi-omics research initiative to decipher genetic susceptibility to pemphigus, a potentially life-threatening autoimmune blistering skin disease affecting approximately...
East Carolina University was awarded $226,500 by the National Institute of Allergy and Infectious Diseases (NIAID) under the Allergy and Infectious Diseases Research program (CFDA 93.855) on February 9, 2026, for a project completion deadline of January 31, 2028. The award supports biomedical research investigating how the Yersinia pestis inner membrane protein YbtX and competition for host zinc influence the progression of pneumonic plague, the most lethal form of plague. Research activities will characterize the relationship between zinc depletion and inflammation during infection, and will employ a murine intranasal infection model to evaluate how alterations in the host zinc and calprotectin balance affect pulmonary inflammatory responses. The project delivers original research findings on the molecular mechanisms underlying pneumonic plague pathogenesis, with specific focus on understanding how bacterial zinc acquisition systems contribute to the hyper-inflammatory response that drives disease lethality. By examining the role of YbtX-mediated zinc import and calprotectin-dependent inflammatory responses, the research will generate scientific knowledge applicable to understanding infectious disease mechanisms and may inform future therapeutic interventions for this rapidly progressive, high-mortality infection.Federal Grant Award Summary
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | $226.5k | 2/9/26 |